Siderowf AD - Search Results

1

The EQ-5D--a generic quality of life measure--is a useful instrument to measure quality of life in patients with Parkinson's disease.

Siderowf AD, Werner RM. Siderowf AD, et al. J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):817. doi: 10.1136/jnnp.70.6.817. J Neurol Neurosurg Psychiatry. 2001. PMID: 11430299 Free PMC article. No abstract available.

2

Design of comprehensive Alzheimer's disease centers to address unmet national needs.

Trojanowski JQ, Arnold SE, Karlawish JH, Brunden K, Cary M, Davatzikos C, Detre J, Gaulton G, Grossman M, Hurtig H, Jedrziewski K, McCluskey L, Naylor M, Polsky D, Schellenberg GD, Siderowf A, Shaw LM, Van Deerlin V, Wang LS, Werner R, Xie SX, Lee VM. Trojanowski JQ, et al. Alzheimers Dement. 2010 Mar;6(2):150-5. doi: 10.1016/j.jalz.2009.11.004. Alzheimers Dement. 2010. PMID: 20298979 Free PMC article.

3

Preference-based quality-of-life in patients with Parkinson's disease.

Siderowf A, Ravina B, Glick HA. Siderowf A, et al. Neurology. 2002 Jul 9;59(1):103-8. doi: 10.1212/wnl.59.1.103. Neurology. 2002. PMID: 12105315

4

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.

Ravina B, Putt M, Siderowf A, Farrar JT, Gillespie M, Crawley A, Fernandez HH, Trieschmann MM, Reichwein S, Simuni T. Ravina B, et al. J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):934-9. doi: 10.1136/jnnp.2004.050682. J Neurol Neurosurg Psychiatry. 2005. PMID: 15965198 Free PMC article. Clinical Trial.

5

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.

Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D. Hoops S, et al. Among authors: siderowf ad. Neurology. 2009 Nov 24;73(21):1738-45. doi: 10.1212/WNL.0b013e3181c34b47. Neurology. 2009. PMID: 19933974 Free PMC article.

6

Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety.

Simuni T, Jaggi JL, Mulholland H, Hurtig HI, Colcher A, Siderowf AD, Ravina B, Skolnick BE, Goldstein R, Stern MB, Baltuch GH. Simuni T, et al. Among authors: siderowf ad. J Neurosurg. 2002 Apr;96(4):666-72. doi: 10.3171/jns.2002.96.4.0666. J Neurosurg. 2002. PMID: 11990805 Clinical Trial.

7

Health-related quality-of-life scales in Parkinson's disease: critique and recommendations.

Martinez-Martin P, Jeukens-Visser M, Lyons KE, Rodriguez-Blazquez C, Selai C, Siderowf A, Welsh M, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG, Schrag A. Martinez-Martin P, et al. Mov Disord. 2011 Nov;26(13):2371-80. doi: 10.1002/mds.23834. Epub 2011 Jul 6. Mov Disord. 2011. PMID: 21735480 Review.

8

Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study.

Weintraub D, Papay K, Siderowf A; Parkinson's Progression Markers Initiative. Weintraub D, et al. Neurology. 2013 Jan 8;80(2):176-80. doi: 10.1212/WNL.0b013e31827b915c. Neurology. 2013. PMID: 23296128 Free PMC article.

9

Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease.

Dams J, Klotsche J, Bornschein B, Reese JP, Balzer-Geldsetzer M, Winter Y, Schrag A, Siderowf A, Oertel WH, Deuschl G, Siebert U, Dodel R. Dams J, et al. Health Qual Life Outcomes. 2013 Mar 8;11:35. doi: 10.1186/1477-7525-11-35. Health Qual Life Outcomes. 2013. PMID: 23497005 Free PMC article.

10

Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities.

Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, Siderowf A, Schapira AH, Oertel W, Obeso JA, Olanow CW, Poewe W, Stern M. Berg D, et al. Lancet Neurol. 2013 May;12(5):514-24. doi: 10.1016/S1474-4422(13)70047-4. Epub 2013 Apr 11. Lancet Neurol. 2013. PMID: 23582175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

229 results

Search Page